PYRAMID_HEALTH_LIMITED - Accounts


Company Registration No. 11893043 (England and Wales)
PYRAMID HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
PAGES FOR FILING WITH REGISTRAR
PYRAMID HEALTH LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
PYRAMID HEALTH LIMITED
BALANCE SHEET
AS AT
31 MARCH 2021
31 March 2021
- 1 -
2021
2020
Notes
£
£
£
£
Fixed assets
Tangible assets
3
3,905
763
Investment properties
4
235,120
235,120
Investments
5
40
40
239,065
235,923
Current assets
Debtors
6
3,960
-
0
Cash at bank and in hand
607,790
320,110
611,750
320,110
Creditors: amounts falling due within one year
7
(651,674)
(329,970)
Net current liabilities
(39,924)
(9,860)
Net assets
199,141
226,063
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
199,041
225,963
Total equity
199,141
226,063

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.

For the financial year ended 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 13 September 2021 and are signed on its behalf by:
S Boam
Director
Company Registration No. 11893043
PYRAMID HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
- 2 -
1
Accounting policies
Company information

Pyramid Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 Coventry Innovation Village, Cheetah Road, Coventry, CV1 2TL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of investment properties at fair value. The principal accounting policies adopted are set out below.

1.2
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Computer equipment
33% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.3
Investment properties

Investment property, which is property held to earn rentals and for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

PYRAMID HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 3 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

PYRAMID HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2021
2020
Number
Number
Total
2
2
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2020
779
Additions
4,049
At 31 March 2021
4,828
Depreciation and impairment
At 1 April 2020
16
Depreciation charged in the year
907
At 31 March 2021
923
Carrying amount
At 31 March 2021
3,905
At 31 March 2020
763
PYRAMID HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 5 -
4
Investment property
2021
£
Fair value
At 1 April 2020 and 31 March 2021
235,120

The directors consider the fair value of the investment property to be the equivalent to the cost of £235,120.

5
Fixed asset investments
2021
2020
£
£
Other investments other than loans
40
40
6
Debtors
2021
2020
Amounts falling due within one year:
£
£
Other debtors
3,960
-
0
7
Creditors: amounts falling due within one year
2021
2020
£
£
Other creditors
649,514
327,810
Accruals and deferred income
2,160
2,160
651,674
329,970
8
Called up share capital
2021
2020
2021
2020
Ordinary share capital
Number
Number
£
£
Issued and fully paid
A Ordinary of £1 each
60
60
60
60
T1 Ordinary of £1 each
10
10
10
10
T2 Ordinary of £1 each
10
10
10
10
T3 Ordinary of £1 each
10
10
10
10
T4 Ordinary of £1 each
10
10
10
10
100
100
100
100
9
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

PYRAMID HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
9
Related party transactions
(Continued)
- 6 -
2021
2020
Amounts due to related parties
£
£
Key management personnel
649,514
327,810

The amounts due to key management personnel are unsecured and are repayable on demand.

2021-03-312020-04-01false14 September 2021CCH SoftwareCCH Accounts Production 2021.200No description of principal activityS BoamN Boamtrue118930432020-04-012021-03-31118930432021-03-31118930432020-03-3111893043core:OtherPropertyPlantEquipment2021-03-3111893043core:OtherPropertyPlantEquipment2020-03-3111893043core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3111893043core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-3111893043core:CurrentFinancialInstruments2021-03-3111893043core:CurrentFinancialInstruments2020-03-3111893043core:ShareCapital2021-03-3111893043core:ShareCapital2020-03-3111893043core:RetainedEarningsAccumulatedLosses2021-03-3111893043core:RetainedEarningsAccumulatedLosses2020-03-3111893043bus:Director12020-04-012021-03-3111893043core:ComputerEquipment2020-04-012021-03-311189304312020-04-012021-03-31118930432019-03-202020-03-3111893043core:OtherPropertyPlantEquipment2020-03-3111893043core:OtherPropertyPlantEquipment2020-04-012021-03-31118930432020-03-3111893043core:WithinOneYear2021-03-3111893043core:WithinOneYear2020-03-3111893043bus:OrdinaryShareClass12020-04-012021-03-3111893043bus:OrdinaryShareClass22020-04-012021-03-3111893043bus:OrdinaryShareClass32020-04-012021-03-3111893043bus:OrdinaryShareClass42020-04-012021-03-3111893043bus:OrdinaryShareClass52020-04-012021-03-3111893043bus:OrdinaryShareClass12021-03-3111893043bus:OrdinaryShareClass12020-03-3111893043bus:OrdinaryShareClass22021-03-3111893043bus:OrdinaryShareClass22020-03-3111893043bus:OrdinaryShareClass32021-03-3111893043bus:OrdinaryShareClass32020-03-3111893043bus:OrdinaryShareClass42021-03-3111893043bus:OrdinaryShareClass42020-03-3111893043bus:OrdinaryShareClass52021-03-3111893043bus:OrdinaryShareClass52020-03-3111893043bus:OrdinaryShareClass12019-03-202020-03-3111893043bus:OrdinaryShareClass22019-03-202020-03-3111893043bus:OrdinaryShareClass32019-03-202020-03-3111893043bus:OrdinaryShareClass42019-03-202020-03-3111893043bus:OrdinaryShareClass52019-03-202020-03-3111893043bus:PrivateLimitedCompanyLtd2020-04-012021-03-3111893043bus:SmallCompaniesRegimeForAccounts2020-04-012021-03-3111893043bus:FRS1022020-04-012021-03-3111893043bus:AuditExemptWithAccountantsReport2020-04-012021-03-3111893043bus:Director22020-04-012021-03-3111893043bus:FullAccounts2020-04-012021-03-31xbrli:purexbrli:sharesiso4217:GBP